|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | |||
| Marketable securities | |||
| Research and development credit | |||
| Prepaid expenses and other current assets | |||
| Total current assets | |||
| Property and equipment, net | |||
| Other assets | |||
| Total assets | |||
| Liabilities and shareholders’ equity | |||
| Current liabilities: | |||
| Accounts payable | |||
| Accrued expenses and other liabilities | |||
| Total current liabilities | |||
| Long-term lease obligations | |||
| Total liabilities | |||
| Shareholders’ equity: | |||
| Ordinary shares, £0.01 nominal value; 100,000 shares authorized as of March 31, 2019 and December 31, 2018; 33,484 and 33,486 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively | |||
| Additional paid-in capital | |||
| Accumulated other comprehensive income (loss): | |||
| Cumulative foreign currency translation adjustment | |||
| Unrealized holding gains on available for sales securities | |||
| Total accumulated other comprehensive loss | |||
| Accumulated deficit | |||
| Total shareholders’ equity | |||
| Total liabilities and shareholders’ equity |
Loading...
